InsidersTradesSigma
Explore the complete record of transactions filed by GEMAYEL GEORGES, Director. Insider active across 1 companies, notably Supernus Pharmaceuticals, INC.. Aggregated, 3 filings have been logged. Total volume traded: €923k. The latest transaction was filed on 5 March 2026 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Georges Gemayel is a Board Member at Supernus Pharmaceuticals, Inc. He provides expertise in corporate governance and strategy. His role on the board is essential for guiding strategic decisions and ensuring the company's regulatory compliance. Georges Gemayel is recognized for his ability to analyze market trends and advise on best management practices.